We are live on ! Find out more
EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

1 hedge funds and large institutions have $423K invested in Eiger BioPharmaceuticals, Inc. in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

45% less capital invested

Capital invested by funds: $765K → $423K (-$342K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PBM
1
Propel Bio Management
California
$423K – – –

EIGR Hedge Fund Activity: Q1 2025 in Review

1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Eiger BioPharmaceuticals, Inc. (EIGR) for Q1 2025, worth a combined $423K — down 45% from $765K a quarter earlier.

Fund positioning in EIGR was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Eiger BioPharmaceuticals, Inc. (EIGR) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $423K of Eiger BioPharmaceuticals, Inc. stock for Q1 2025, down 45% quarter-over-quarter.
  • 0 funds opened new Eiger BioPharmaceuticals, Inc. positions in Q1 2025 and 0 closed out.

Based on aggregated 13F filings for Q1 2025.